| |
| |
|
| Insider
Information: |
Schuth Alexander O. |
| Relationship: |
COFO and Secretary |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
178,066 |
|
|
Indirect Shares
|
523,749 |
|
|
| Direct
Value |
$5,477,310 |
|
|
|
Indirect Value
|
$16,110,519 |
|
|
| Total
Shares |
701,815 |
|
|
| Total
Value |
$21,587,829 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -127.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
COFO and Secretary |
2024-08-21 |
178,066 |
2024-08-21 |
523,749 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-11-26 |
4 |
AS |
$18.02 |
$4,127 |
I/I |
(229) |
584,378 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-11-22 |
4 |
AS |
$18.00 |
$11,628 |
I/I |
(646) |
598,732 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-12-03 |
4 |
AS |
$18.01 |
$12,805 |
D/D |
(711) |
25,839 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-12-03 |
4 |
OE |
$5.28 |
$3,754 |
D/D |
711 |
26,550 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-12-03 |
4 |
AS |
$18.01 |
$18,226 |
I/I |
(1,012) |
583,366 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2022-02-09 |
4 |
S |
$37.10 |
$52,800 |
I/I |
(1,423) |
460,564 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2020-03-30 |
4 |
S |
$19.49 |
$27,812 |
D/D |
(1,427) |
28,662 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-02-09 |
4 |
S |
$74.66 |
$109,809 |
I/I |
(1,468) |
537,344 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-02-08 |
4 |
S |
$30.89 |
$46,984 |
I/I |
(1,521) |
499,902 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2020-08-21 |
4 |
D |
$32.88 |
$64,248 |
I/I |
(1,954) |
614,562 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-08-21 |
4 |
D |
$18.60 |
$36,731 |
D/D |
(1,975) |
20,710 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2024-08-13 |
4 |
S |
$22.89 |
$52,006 |
D/D |
(2,272) |
186,419 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-03-11 |
4 |
AS |
$21.20 |
$52,635 |
I/I |
(2,475) |
660,114 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-04-09 |
4 |
AS |
$28.17 |
$69,721 |
I/I |
(2,475) |
652,614 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-08-21 |
4 |
S |
$22.59 |
$55,978 |
I/I |
(2,478) |
521,511 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2018-12-10 |
4 |
AS |
$20.18 |
$50,450 |
I/I |
(2,500) |
682,589 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2018-12-11 |
4 |
AS |
$20.22 |
$50,550 |
I/I |
(2,500) |
680,089 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2018-12-12 |
4 |
AS |
$20.80 |
$52,000 |
I/I |
(2,500) |
677,589 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-01-09 |
4 |
AS |
$20.31 |
$50,775 |
I/I |
(2,500) |
675,089 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-01-10 |
4 |
AS |
$19.99 |
$49,975 |
I/I |
(2,500) |
672,589 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-01-11 |
4 |
AS |
$20.80 |
$52,000 |
I/I |
(2,500) |
670,089 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-02-08 |
4 |
AS |
$18.11 |
$45,275 |
I/I |
(2,500) |
667,589 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-02-11 |
4 |
AS |
$18.74 |
$47,622 |
I/I |
(2,500) |
665,089 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-02-12 |
4 |
AS |
$19.73 |
$50,192 |
I/I |
(2,500) |
662,589 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-05-09 |
4 |
AS |
$22.86 |
$57,150 |
I/I |
(2,500) |
645,089 |
0 |
- |
|
93 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
